Category Specific RSS

mdma

Vitura’s Cortexa becomes first Aus company to supply ecstasy and magic mushrooms under TGA’s prescriber scheme

In July last year, Australia became the first country to legalise ecstasy (MDMA) and magic mushrooms (psilocybin) for mental health…

1 year ago

Vitura receives first MDMA for its newly-minted psychedelics arm Cortexa

In May 2023, diversified digital health company Vitura Health (ASX: VIT) announced a joint venture with Canadian psychedelic company PharmAla…

2 years ago

Melodiol reports positive results from Halucenex trials for magic mushrooms to treat PTSD

In Australia, about 43% of people aged between 16 and 85 had experienced a mental disorder at some point as…

2 years ago

Cann Group poised for growth as demand for locally produced cannabis surges

Australia has made a groundbreaking decision by becoming the first country to legalise the clinical prescribing of MDMA (ecstasy) and…

2 years ago

Treating mental health; TGA approves MDMA and Psilocybin as a medicine

Although it doesn’t apply to me, many of you may remember the early mornings during adolescence when you were throwing…

2 years ago

Does IP ownership of MDMA compounds reduce its potential for healthcare benefits?

If you read my articles often, you would know that I can become quite laudatory when discussing small cap companies…

3 years ago